Patents by Inventor Michael C. MacLeod

Michael C. MacLeod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7294487
    Abstract: The present invention relates to a method for the detection of gene expression and analysis of both known and unknown genes. The invention is a highly sensitive, rapid and cost-effective means of monitoring gene expression, as well as for the analysis and quantitation of changes in gene expression for a defined set of genes and in response to a wide variety of events.” It is an important feature of the present invention that no single molecular species of cDNA gives rise to more than one fragment in the collection of products which are subsequently amplified and representative of each expressed gene. This achievement is facilitated by immobilizing the cDNA prior to digesting and then digesting with sequentially with two frequently cutting enzymes. Linker oligomers are ligated to each cut site following the respective digestion. Primers, complementary to the oligomer sequence with an additional 3? variable sequence are used to amplify the fragments.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: November 13, 2007
    Assignee: Board of Regents, the University of Texas System
    Inventors: Michael C. MacLeod, C. Marcelo Aldaz, Sara S. Gaddis
  • Publication number: 20030027141
    Abstract: The present invention relates to a method for the detection of gene expression and analysis of both known and unknown genes. The invention is a highly sensitive, rapid and cost-effective means of monitoring gene expression, as well as for the analysis and quantitation of changes in gene expression for a defined set of genes and in response to a wide variety of events.” It is an important feature of the present invention that no single molecular species of cDNA gives rise to more than one fragment in the collection of products which are subsequently amplified and representative of each expressed gene. This achievement is facilitated by immobilizing the cDNA prior to digesting and then digesting with sequentially with two frequently cutting enzymes. Linker oligomers are ligated to each cut site following the respective digestion. Primers, complementary to the oligomer sequence with an additional 3′ variable sequence are used to amplify the fragments.
    Type: Application
    Filed: April 23, 2001
    Publication date: February 6, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Michael C. MacLeod, C. Marcelo Aldaz, Sara S. Gaddis
  • Patent number: 6221600
    Abstract: The present invention relates to a method for the detection of gene expression and analysis of both known and unknown genes. The invention is a highly sensitive, rapid and cost-effective means of monitoring gene expression, as well as for the analysis and quantitation of changes in gene expression for a defined set of genes and in response to a wide variety of events. It is an important feature of the present invention that no single molecular species of cDNA gives rise to more than one fragment in the collection of products which are subsequently amplified and representative of each expressed gene. This achievement is facilitated by immobilizing the cDNA prior to digesting and then digesting with sequentially with two frequently cutting enzymes. Linker oligomers are ligated to each cut site following the respective digestion. Primers, complementary to the oligomer sequence with an additional 3′ variable sequence are used to amplify the fragments.
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: April 24, 2001
    Assignee: Board of Regents, The University of Texas System
    Inventors: Michael C. MacLeod, C. Marcelo Aldaz, Sara S. Gaddis
  • Patent number: 5231108
    Abstract: Analogs of 6-mercaptopurine have been found to enhance the detoxification of various electrophilic toxicants in vivo, while having minimal cytotoxicity themselves. This property allows such compounds to act as scavengers for electrophilic toxicants, thereby preventing the cellular damage caused by such toxic agents.
    Type: Grant
    Filed: March 4, 1992
    Date of Patent: July 27, 1993
    Assignee: The Board of Regents, The University of Texas System
    Inventor: Michael C. MacLeod
  • Patent number: 5120753
    Abstract: Analogs of 6-mercaptopurine have been found to enhance the detoxification of various electrophilic toxicants in vivo, while having minimal cytotoxicity themselves. This property allows such compounds to act as scavengers for electrophilic toxicants, thereby preventing the cellular damage caused by such toxic agents.
    Type: Grant
    Filed: September 17, 1990
    Date of Patent: June 9, 1992
    Assignee: Board of Regents, The University of Texas System
    Inventor: Michael C. MacLeod